The future of oncology seems to lie in Molecular Medicine (MM). MM is a
new science based on three pillars. Two of them are evident in its very
name and are well known: medical science and molecular biology. However,
there is a general unawareness that MM is firmly based on a third, and
equally important, pillar: Systems Biomedicine. Currently, this term
denotes multilevel, hierarchical models integrating key factors at the
molecular, cellular, tissue, through phenotype levels, analyzed to
reveal the global behavior of the biological process under
consideration. It becomes increasingly evident that the tools to
construct such complex models include, not only bioinformatics and
modern applied statistics, as is unanimously agreed, but also other
interdisciplinary fields of science, notably, Mathematical Oncology,
Systems Biology and Theoretical Biophysics.